Elevation of transforming growth factor-β1 is associated with recurrent miscarriage

被引:57
作者
Ogasawara, MS [1 ]
Aoki, K
Aoyama, T
Katano, K
Iinuma, Y
Ozaki, Y
Suzumori, K
机构
[1] Nagoya City Univ, Sch Med, Dept Obstet & Gynecol, Mizuho Ku, Nagoya, Aichi 4678601, Japan
[2] Nagoya City Johsai Hosp, Dept Obstet & Gynecol, Nagoya, Aichi 453, Japan
关键词
transforming growth factor beta 1; pregnancy; miscarriage; recurrent miscarriage;
D O I
10.1023/A:1026459800016
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To investigate the significance of transforming growth factor-beta1 (TGF-beta1) in reproduction We have compared plasma levels in normal pregnant women and patients suffering miscarriages. We examined 188 normal pregnant women and 12 pregnant women with miscarriages, Eight women With severe recurrent miscarriages (mean +/- SD of previous number of miscarriages; 10.4 +/- 2.4 times) were also examined before conception; 34 nonpregnant women served as controls. Plasma TGF-beta1 level increased with the gestational week and returned within the normal range 1 month after delivery. The levels among pregnant women with miscarriages (mean +/- SD; 2.44 +/- 0.83 ng/ml) were significantly higher than those of pregnant controls (1.74 +/- 0.95 ng/ml) of matched gestational weeks; levels among nonpregnant women with severe recurrent miscarriages were extremely elevated (4.1 +/- 3.04 ng/ml) compared to the control value (1.34 +/- 0.59 ng/ml). These data suggest that TGF-beta1 may he necessary to maintain pregnancy but also may be a risk factor Fur recurrent miscarriages.
引用
收藏
页码:453 / 457
页数:5
相关论文
共 21 条
[1]   PRECONCEPTIONAL NATURAL-KILLER-CELL ACTIVITY AS A PREDICTOR OF MISCARRIAGE [J].
AOKI, K ;
KAJIURA, S ;
MATSUMOTO, Y ;
OGASAWARA, M ;
OKADA, S ;
YAGAMI, Y ;
GLEICHER, N .
LANCET, 1995, 345 (8961) :1340-1342
[2]  
BELLONE G, 1995, J IMMUNOL, V155, P1066
[3]   Localization of IL-4 and IL-4 receptors in the human term placenta, decidua and amniochorionic membranes [J].
deMoraesPinto, MI ;
Vince, GS ;
Flanagan, BF ;
Hart, CA ;
Johnson, PM .
IMMUNOLOGY, 1997, 90 (01) :87-94
[4]   TRANSFORMING GROWTH FACTOR-BETA-1 EXPRESSION DURING PLACENTAL DEVELOPMENT [J].
DUNGY, LJ ;
SIDDIQI, TA ;
KHAN, S .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1991, 165 (04) :853-857
[5]   PURIFICATION AND INITIAL CHARACTERIZATION OF A TYPE-BETA TRANSFORMING GROWTH-FACTOR FROM HUMAN-PLACENTA [J].
FROLIK, CA ;
DART, LL ;
MEYERS, CA ;
SMITH, DM ;
SPORN, MB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (12) :3676-3680
[6]  
Goodwin VJ, 1998, AM J REPROD IMMUNOL, V40, P319
[7]   LOCALIZATION OF TRANSFORMING GROWTH-FACTOR-BETA AT THE HUMAN FETAL-MATERNAL INTERFACE - ROLE IN TROPHOBLAST GROWTH AND DIFFERENTIATION [J].
GRAHAM, CH ;
LYSIAK, JJ ;
MCCRAE, KR ;
LALA, PK .
BIOLOGY OF REPRODUCTION, 1992, 46 (04) :561-572
[8]   MECHANISM OF CONTROL OF TROPHOBLAST INVASION INSITU [J].
GRAHAM, CH ;
LALA, PK .
JOURNAL OF CELLULAR PHYSIOLOGY, 1991, 148 (02) :228-234
[9]   OPPOSING ACTIONS OF TRANSFORMING GROWTH-FACTOR-BETA AND GLUCOCORTICOIDS IN THE REGULATION OF FIBRONECTIN EXPRESSION IN THE HUMAN PLACENTA [J].
GULLER, S ;
WOZNIAK, R ;
KONG, L ;
LOCKWOOD, CJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (11) :3273-3278
[10]  
IGNOTZ RA, 1986, J BIOL CHEM, V261, P4337